362210166	362210166	CD	B-NP	O
|	|	NN	I-NP	O
CCGH	CCGH	NN	I-NP	O
|	|	NN	I-NP	O
31835063	31835063	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0764315	0764315	CD	B-NP	O
|	|	CC	I-NP	O
3/19/2004	3/19/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CORONARY	CORONARY	NNP	I-NP	I-protein
ARTERY	ARTERY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/1/2004	8/1/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/20/2004	11/20/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DONNIE	DONNIE	NNP	B-NP	O
NEISEN	NEISEN	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
83-year-old	83-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Clinch	Clinch	NNP	B-NP	O
University	University	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
10/18/04	10/18/04	CD	B-NP	O
with	with	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
while	while	IN	B-SBAR	O
driving	drive	VBG	B-VP	O
a	a	DT	B-NP	O
motor	motor	NN	I-NP	O
vehicle	vehicle	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
sustained	sustain	VBD	B-VP	O
a	a	DT	B-NP	O
left-sided	left-sided	JJ	I-NP	O
rib	rib	NN	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
that	that	IN	B-NP	O
time	time	NN	B-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
performed	perform	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Persantine	Persantine	JJ	I-NP	O
testing	testing	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
suspect	suspect	VBP	B-VP	O
reversible	reversible	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
apical	apical	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
today	today	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
triple	triple	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
developed	develop	VBD	B-VP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
post-catheterization	post-catheterization	NN	I-NP	O
with	with	IN	B-PP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
with	with	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
and	and	CC	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
and	and	CC	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

CABG	CABG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Vannorden	Vannorden	NNP	I-NP	O
Trauma	Trauma	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
to	to	TO	I-VP	O
clear	clear	VB	I-VP	O
him	him	PRP	B-NP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

Urology	Urology	NNP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
hematuria	hematuria	NN	B-NP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
neurological	neurological	JJ	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
triple	triple	JJ	B-NP	O
AAA	AAA	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
left	left	JJ	B-NP	O
rib	rib	NN	I-NP	O
fractures	fracture	NNS	I-NP	O
,	,	,	O	O
bladder	bladder	NN	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
adrenal	adrenal	JJ	B-NP	O
adenoma	adenoma	NN	I-NP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
ready	ready	JJ	B-ADJP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
10/20/04	10/20/04	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
off	off	JJ	I-NP	O
pump	pump	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
with	with	IN	B-PP	O
LIMA	LIMA	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
intraoperative	intraoperative	JJ	I-NP	O
findings	finding	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
OM2	OM2	NN	I-NP	B-protein
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
date	date	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
an	an	DT	B-NP	O
EP	EP	NN	I-NP	O
study	study	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
ready	ready	JJ	B-ADJP	O
for	for	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
Step-Down	Step-Down	JJ	B-NP	O
Unit	Unit	NNP	I-NP	O
by	by	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
getting	get	VBG	I-VP	O
Lopressor	Lopressor	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
80	80	CD	B-NP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
90	90	CD	B-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
within	within	IN	B-PP	O
five	five	CD	B-NP	O
hours	hour	NNS	I-NP	O
postoperative	postoperative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
with	with	IN	B-PP	O
sats	sat	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
90s	90	NNS	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
pending	pende	VBG	B-PP	O
his	his	PRP$	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
swallowing	swallow	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
age	age	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresing	diurese	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Urology	Urology	NNP	B-NP	O
was	be	VBD	B-VP	O
following	follow	VBG	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
required	require	VBD	B-VP	O
bladder	bladder	NN	B-NP	O
flushes	flush	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
urine	urine	NN	I-NP	O
became	become	VBD	B-VP	O
cloudy	cloudy	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
in	in	IN	B-PP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
chest	ch	JJS	I-NP	O
tubes	tube	NNS	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
epicardial	epicardial	JJ	I-NP	B-DNA
pacing	pacing	NN	I-NP	I-DNA
wires	wire	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
left	leave	VBN	I-VP	O
in	in	IN	B-PP	O
and	and	CC	O	O
EP	EP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
evaluating	evaluate	VBG	I-VP	O
him	him	PRP	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
preoperative	preoperative	JJ	I-NP	O
syncopal	syncopal	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
was	be	VBD	B-VP	O
following	follow	VBG	I-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
him	him	PRP	B-NP	O
having	have	VBG	B-VP	O
done	do	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
in	in	IN	B-PP	O
secondary	secondary	JJ	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
hematuria	hematuria	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
wires	wire	NNS	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
went	go	VBD	B-VP	O
into	into	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
time	time	NN	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
titrating	titrate	VBG	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
spoke	speak	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Urology	Urology	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
__________	__________	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Horwath	Horwath	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	JJ	I-NP	O
done	done	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
trace	trace	NN	B-NP	B-protein
MR	MR	NN	I-NP	I-protein
and	and	CC	O	O
trace	trace	NN	B-NP	B-protein
TR	TR	NN	I-NP	I-protein
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
basal	basal	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
off	off	IN	B-ADVP	O
Motrin	Motrin	NNP	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
loading	load	VBG	I-NP	O
20	20	CD	I-NP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sating	sate	VBG	I-VP	O
91	91	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
preoperative	preoperative	JJ	I-NP	O
captopril	captopril	NN	I-NP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
to	to	TO	B-PP	O
160	160	CD	B-NP	O
systolically	systolically	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
suitable	suitable	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
on	on	IN	B-PP	O
6/23/04	6/23/04	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Included	Include	VBD	B-VP	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
baby	baby	NN	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Proscar	Proscar	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Humalog	Humalog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Carbohydrate	Carbohydrate	VB	B-VP	O
controlled	control	VBN	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
low-cholesterol	low-cholesterol	NN	B-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
saturated	saturate	VBN	I-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	B-NP	O
calories	calorie	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
make	make	NN	B-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
appointments	appointment	NNS	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Hodgens	Hodgens	NNP	I-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Bowell	Bowell	NNP	I-NP	O
from	from	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Thrams	Thrams	NNP	I-NP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
four	four	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Calvo	Calvo	NNP	I-NP	O
from	from	IN	B-PP	O
Urology	Urology	NNP	B-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
instructions	instruction	NNS	I-NP	O
included	include	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placed	place	VBN	B-VP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
OM	OM	NN	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
plans	plan	VBZ	B-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
stenting	stente	VBG	I-VP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
after	after	IN	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

EPS	EPS	NNS	B-NP	B-protein
will	will	MD	B-VP	O
place	place	VB	I-VP	O
pacemaker	pacemaker	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
the	the	DT	B-NP	O
stent	stent	JJ	I-NP	O
placement	placement	NN	I-NP	O
by	by	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
with	with	IN	B-PP	O
AICD	AICD	NN	B-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	O	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
urology	urology	NN	B-NP	O
,	,	,	O	O
local	local	JJ	B-NP	O
wound	wound	NN	I-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
continue	continue	JJ	B-NP	O
ambulation	ambulation	NN	I-NP	O
,	,	,	O	O
shower	shower	NN	B-NP	O
patient	patient	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
keep	keep	VB	B-VP	O
legs	leg	NNS	B-NP	O
elevated	elevate	VBN	B-VP	O
while	while	IN	B-SBAR	O
seated	seat	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
chair	chair	NN	I-NP	O
and	and	CC	I-NP	O
bed	bed	NN	I-NP	O
,	,	,	O	O
monitor	monitor	NN	B-NP	O
CV	CV	NN	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
glucometer	glucometer	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
discharge	discharge	NN	I-NP	O
laboratory	laboratory	NN	I-NP	O
values	value	NNS	I-NP	O
included	include	VBD	B-VP	O
sodium	sodium	NN	B-NP	O
134	134	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.5	4.5	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
44	44	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.5	1.5	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	B-protein
127	127	CD	I-NP	I-protein
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
8.3	8.3	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
26.7	26.7	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
237	237	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
PA	PA	NN	I-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-NP	O
revealed	reveal	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lung	lung	NN	I-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-9841773	9-9841773	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
FRAIRE	FRAIRE	NNP	B-NP	O
,	,	,	O	O
EMANUEL	EMANUEL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MERIDETH	MERIDETH	NN	B-NP	O
,	,	,	O	O
TYRON	TYRON	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4284832	4284832	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/30/04	10/30/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/30/04	10/30/04	CD	B-NP	O

